Trademark: 90025742
Word
OPTICYTE
Status
Registered
Status Code
700
Status Date
Tuesday, January 26, 2021
Serial Number
90025742
Registration Number
6256450
Registration Date
Tuesday, January 26, 2021
Mark Type
4000
Filing Date
Monday, June 29, 2020
Published for Opposition
Tuesday, November 10, 2020

Trademark Owner History

Classifications
5 Human biological amniotic membrane or other postpartum tissues intended for subsequent implantation; human biological amniotic tissue or other postpartum tissues that may include amniotic membrane, amniotic fluid, umbilical cord, or placenta, intended for medical use for the treatment or prevention of ophthalmic diseases, or the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye; human biological tissue, namely, placental-derived tissue for use in biological tissue grafts for use in surgery and wound repair involving the eye; topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye, and the treatment or prevention of ophthalmic diseases; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye; wound treatment in the nature of amniotic material prepared in sheet forms or viscous forms

Trademark Events
Jan 25, 2023
Automatic Update Of Assignment Of Ownership
Jan 26, 2021
Registered-Principal Register
Nov 10, 2020
Official Gazette Publication Confirmation E-Mailed
Nov 10, 2020
Published For Opposition
Oct 21, 2020
Notification Of Notice Of Publication E-Mailed
Sep 30, 2020
Approved For Pub - Principal Register
Sep 30, 2020
Assigned To Examiner
Jul 25, 2020
New Application Office Supplied Data Entered
Jul 2, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24